Evidence that FGFR plays a functional role in N-cadherin-mediated cancer metastasis has been demonstrated in BT-20 and PyMT breast cancer cells, whereby FGFR inhibition reduced the in vitro migratory capacity of N-cadherin-expressing cells, but not N-cadherin-negative cells [45, 84]. Here, CDH2 is linked to breast carcinoma.